Implementation of a biomaterial database for the identification of biomarkers for the monitoring and transdiagnostic prediction of response to electroconvulsive therapy (ECT)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033682

Enrollment

400

Registered

2024-02-20

Start date

2018-11-12

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive and further psychiatric syndromes for which ECT is indicated

Interventions

Group 1: Patients with severe or treatment resistent depressive and psychotic syndromes

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Indication for ECT

Exclusion criteria

Exclusion criteria: - patients detained or with involuntary treatment - acute or chronic infectious disease

Design outcomes

Primary

Measure	Time frame
Identification of molecular markers for response prediction. Response is defined using the Montgomery Asberg Depression Rating Scale (MADRS) for depressive disorders, and Clinical Global Impression Scale (CGI) in psychotic disorders	—

Secondary

Measure	Time frame
BDI-II scale	—

Countries

Germany

Contacts

Public ContactDavid Zilles-Wegner

Klinik für Psychiatrie und Psychotherapie

david.zilles-wegner@med.uni-goettingen.de+ 49 551 39 60607

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026